Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease
NCT01045096
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroesophageal Reflux
Interventions
DRUG:
Dexlansoprazole
DRUG:
Dexlansoprazole
DRUG:
Dexlansoprazole
Sponsor
Takeda